Showing results (271-280 of 742) with videos related to

Sort By:
Pageof 75
European Journal of Haematology|November 24, 2020
Characterization and prognostic implication of delayed complete response in AL amyloidosisEli Muchtar, Morie A Gertz, Shaji K Kumar, et al.
American Journal of Hematology|July 19, 2020
Refining amyloid complete hematological response: Quantitative serum free light chains superior to ratioEli Muchtar, Morie A Gertz, Martha Q Lacy, et al.
American Journal of Hematology|October 4, 2025
Clinical Characteristics, Treatment Responses and Outcomes of Light Chain Multiple MyelomaAbiola Bolarinwa, Saurabh Zanwar, Nadine Abdallah, et al.
Blood Advances|January 30, 2025
Solitary plasmacytoma: single-institution experience, and systematic review and meta-analysis of clinical outcomesCharalampos Charalampous, Jean-Sebastien Claveau, Prashant Kapoor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 2009
Building a protocol expressway: the case of Mayo Clinic Cancer CenterTerre A McJoynt, Muhanad A Hirzallah, Daniel V Satele, et al.
Haematologica|September 5, 2007
Effect of hematologic response on outcome of patients undergoing transplantation for primary amyloidosis: importance of achieving a complete responseMorie A Gertz, Martha Q Lacy, Angela Dispenzieri, et al.
Blood Cancer Journal|June 16, 2026
Metabolic heterogeneity and niche rewiring in bone marrow plasma cells from patients with MGUS, solitary bone plasmacytoma and multiple myelomaGuoxing Zhang, Na Sun, Yogesh Chawla, et al.
American Journal of Hematology|March 18, 2021
Use of endpoints in multiple myeloma randomized controlled trials over the last 15 years: A systematic reviewGhulam Rehman Mohyuddin, Kelly Koehn, Al-Ola Abdallah, et al.
Cancer|October 14, 2004
Incidence of multiple myeloma in Olmsted County, Minnesota: Trend over 6 decadesRobert A Kyle, Terry M Therneau, S Vincent Rajkumar, et al.
Blood Cancer Journal|May 25, 2026
Prevalence of monoclonal gammopathy of undetermined significance (MGUS) using a sensitive mass spectrometry assay in young individuals 10-49 years of age: a population-based study from the National Health and Nutritional Examination SurveyShaji Kumar, David Murray, Dirk R Larson, et al.
Pageof 75